Company news
Carvolix (EURONEXT:CVX) news
Every Carvolix press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Carvolix Takes a Key Step Toward Commercial Launch of TAVIPILOT Software in Europe with Regulatory Submission for CE Marking.
September 9, 2026
Carvolix Secures EUR 30 Million Of Structured Debt Financing To Fuel Its Growth.
August 6, 2026
Carvolix Secures New EUR 10m Tranche, Bringing Total Financing to EUR 20m as Part of its EUR 30m Programme
June 24, 2026
Carvolix announces positive 3-years clinical results for Kalios™ , the only adjustable mitral ring. 100% of patients met primary endpoint...
June 15, 2026
Carvolix Announces Positive Results of the Postmarketing Clinical Program Evaluating the TAVIPILOT AI Software.
May 4, 2026
Carvolix Strengthens its Board of Directors, and International Advisory Bodies
April 9, 2026
Carvolix joins key Euronext indices, marking a new milestone in its capital markets profile.
March 23, 2026
Carvolix : Estimated full-year 2025 results.
March 19, 2026